Gaxosai INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Gaxos.ai Inc. filed its Q2 2026 Form 10-Q, showing a substantial increase in revenues driven by administrative services and subscriptions, but also a significant rise in operating expenses and a net loss attributable to common shareholders.
NASDAQ
Gaxos.AI Inc. reported a significant increase in revenue for the first quarter of 2026, driven by its RNK Health and Gaxos Labs subscription services, though net loss also widened due to increased operating expenses.
NASDAQ
Gaxos.AI reported a significant revenue increase in Q3 2025 driven by its RNK Health and subscription services, though net losses also expanded due to higher operating expenses.
NASDAQ
Gaxos.AI Inc. reported a significant increase in revenue driven by new AI initiatives in gaming and health, though net losses also widened as the company continues heavy investment in development.
NASDAQ
Gaxos.ai Inc. reports increased revenue for Q1 2025, driven primarily by its RNK Health subsidiary, while continuing to invest in AI-powered health and gaming solutions.
NASDAQ
Gaxos.ai Inc. reported its financial results for the third quarter of 2024, highlighting revenue generation from its new Gaxos Health initiative and a decrease in operating expenses.
NASDAQ
Gaxos.ai Inc. reported its financial results for the quarter ended June 30, 2024, highlighting ongoing investments in AI-driven gaming and health platforms.
NASDAQ
Gaxos.ai Inc. reported its first quarter 2024 financial results, showing a net loss but also highlighting progress in its gaming and health initiatives and a recent capital raise.